Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer
Clinical trial NCT07112612 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07112612
- Sponsor
- Anhui Medical University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-30
- Primary completion
- 2026-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.